Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Denim, not discounts: Why Ace Turtle is moving up the value chain
Ace Turtle is shifting away from the value denim segment to focus on premium brands such as Lee and G-Star. It expects 25% revenue growth this fiscal, driven by expansion in tier-II and -III cities, while investing in AI to improve operational efficiency.
General insurance reports 9% GWP growth in FY26
India's general insurance sector saw robust growth in FY26. Gross written premium increased by 9%, reaching ₹3.36 lakh crore. This expansion was fueled by private insurers and strong demand for health and motor policies. Standalone health insurers outperformed, showing a significant 22% rise. This segment continues to be a key driver for the industry's overall success.
General insurance March data: ICICI Lombard grows 21% vs industry 8%
ICICI Lombard leads with 21% March premium growth versus industry 8%, Niva Bupa outperforms health peers, overall general insurance expansion stays moderate.
Aurobindo Pharma approves ₹800 crore share buyback; Check premium, record date and more
This is Aurobindo Pharma's first share buyback in nearly two years. Back in August 2024, the company had announced the repurchase of 51.36 lakh equity shares at a price of ₹1,460 apiece. The drugmaker had spent ₹750 crore for this buyback, which was also carried out via the tender offer route.
Ambuja’s shift from volume chase to value accretion may take time to pay off
After a rapid expansion drive, Ambuja Cements is pivoting to a value-over-volume strategy—focusing on utilization, premium products and cost cuts to boost margins and returns.
Gaudium IVF shares list at 5% premium over issue price
The IPO of Gaudium IVF and Women Health was subscribed 7.27 times at close, driven by sustained demand from retail and non-institutional investors.
Gaudium IVF & Women Health IPO to list at discount? Here's what GMP signals ahead of debut
The shares of Gaudium IVF & Women Health IPO are trading at a premium of ₹-4 in the grey market, as per the websites tracking the grey market.
Acutaas Chemicals: Time to book profit?
After a near-threefold rally, premium valuations leave limited room for error despite strong growth visibility
ICICI Lombard: Significant acceleration in business growth in Q4 FY26
Retail health and motor rebound power insurer’s Q4 surge; profitability discipline keeps premium valuation intact